Literature DB >> 7860615

Analysis of ras mutations in human melanocytic lesions: activation of the ras gene seems to be associated with the nodular type of human malignant melanoma.

M Jafari1, T Papp, S Kirchner, U Diener, D Henschler, G Burg, D Schiffmann.   

Abstract

We have analyzed the Ha-ras, Ki-ras and N-ras gene for point mutations at codons 12, 13 and 61 via restriction fragment length polymorphism/polymerase chain reaction analysis and subsequent direct sequencing in non-cultured fresh-frozen tissues of 16 superficial spreading melanomas (SSM), 13 nodular malignant melanomas (NMM), 2 lentigo malignant melanomas (LMM), 1 dysplastic nevus, 1 congenital nevus and 5 normal nevi from 38 patients. Mutations were found in 4 melanoma samples, all belonging to the nodular malignant type. Three of them were mutated in N-ras and one in the Ha-ras gene. Mutation in N-ras was also detected in the congenital nevus. All mutations were exclusively located at the first two base pairs of codon 61. No Ki-ras mutation was detected in any lesion. No mutation could be found in SSM and LMM in addition to dysplastic and normal nevi. The frequency of ras mutation in NMM was 31%, whereas in SSM it was 0%. Our study suggests (a) an association between ras mutations (mainly N-ras) and the NMM as a subgroup of human melanoma; (b) that activation of Ki-ras is not involved in the pathogenesis of melanoma. The role of UV radiation in point mutations of ras genes in human melanoma is discussed.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7860615     DOI: 10.1007/bf01202725

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  33 in total

1.  Photosensitized formation of 8-hydroxydeoxyguanosine in cellular DNA by riboflavin.

Authors:  F Yamamoto; S Nishimura; H Kasai
Journal:  Biochem Biophys Res Commun       Date:  1992-09-16       Impact factor: 3.575

2.  AciI and BstNI/CfrI detect all possible activating point mutations at codons 13 and 61 of the human H-ras oncogene.

Authors:  T Papp; M Jafari; C Kopp; D Schiffmann
Journal:  Hum Mol Genet       Date:  1992-11       Impact factor: 6.150

3.  Structure and organization of the human Ki-ras proto-oncogene and a related processed pseudogene.

Authors:  J P McGrath; D J Capon; D H Smith; E Y Chen; P H Seeburg; D V Goeddel; A D Levinson
Journal:  Nature       Date:  1983 Aug 11-17       Impact factor: 49.962

4.  N-ras mutations in human cutaneous melanoma from sun-exposed body sites.

Authors:  L J van 't Veer; B M Burgering; R Versteeg; A J Boot; D J Ruiter; S Osanto; P I Schrier; J L Bos
Journal:  Mol Cell Biol       Date:  1989-07       Impact factor: 4.272

5.  Molecular cloning and the total nucleotide sequence of the human c-Ha-ras-1 gene activated in a melanoma from a Japanese patient.

Authors:  T Sekiya; M Fushimi; H Hori; S Hirohashi; S Nishimura; T Sugimura
Journal:  Proc Natl Acad Sci U S A       Date:  1984-08       Impact factor: 11.205

6.  Singlet oxygen: a primary effector in the ultraviolet A/near-visible light induction of the human heme oxygenase gene.

Authors:  S Basu-Modak; R M Tyrrell
Journal:  Cancer Res       Date:  1993-10-01       Impact factor: 12.701

Review 7.  Genotoxicity of singlet oxygen.

Authors:  B Epe
Journal:  Chem Biol Interact       Date:  1991       Impact factor: 5.192

8.  Malignant transformation of human melanocytes: induction of a complete melanoma phenotype and genotype.

Authors:  A P Albino; G Sozzi; D M Nanus; S C Jhanwar; A N Houghton
Journal:  Oncogene       Date:  1992-11       Impact factor: 9.867

9.  Modified ASRA facilitates the characterization of activating point mutations in tumors, in which cancer cells constitute only a minor part of the investigated tissue.

Authors:  T Papp; M Jafari; U Diener; N Dudley; D Schiffmann
Journal:  PCR Methods Appl       Date:  1993-10

10.  Class II histocompatibility antigen expression in human melanocytes transformed by Harvey murine sarcoma virus (Ha-MSV) and Kirsten MSV retroviruses.

Authors:  A P Albino; A N Houghton; M Eisinger; J S Lee; R R Kantor; A I Oliff; L J Old
Journal:  J Exp Med       Date:  1986-11-01       Impact factor: 14.307

View more
  21 in total

1.  Mitogen-activated protein kinases control p27/Kip1 expression and growth of human melanoma cells.

Authors:  M Kortylewski; P C Heinrich; M E Kauffmann; M Böhm; A MacKiewicz; I Behrmann
Journal:  Biochem J       Date:  2001-07-01       Impact factor: 3.857

Review 2.  Melanoma: from mutations to medicine.

Authors:  Hensin Tsao; Lynda Chin; Levi A Garraway; David E Fisher
Journal:  Genes Dev       Date:  2012-06-01       Impact factor: 11.361

Review 3.  Growth factors and oncogenes as targets in melanoma: lost in translation?

Authors:  Lawrence Kwong; Lynda Chin; Stephan N Wagner
Journal:  Adv Dermatol       Date:  2007

4.  Activation of the extracellular signal regulated kinase (ERK) pathway in human melanoma.

Authors:  L Zhuang; C S Lee; R A Scolyer; S W McCarthy; A A Palmer; X D Zhang; J F Thompson; L P Bron; P Hersey
Journal:  J Clin Pathol       Date:  2005-11       Impact factor: 3.411

Review 5.  Superficial spreading and nodular melanoma are distinct biological entities: a challenge to the linear progression model.

Authors:  Holly S Greenwald; Erica B Friedman; Iman Osman
Journal:  Melanoma Res       Date:  2012-02       Impact factor: 3.599

Review 6.  Activated ras. Yet another player in melanoma?

Authors:  M Herlyn; K Satyamoorthy
Journal:  Am J Pathol       Date:  1996-09       Impact factor: 4.307

7.  Oncogenic NRAS cooperates with p53 loss to generate melanoma in zebrafish.

Authors:  Michael Dovey; Richard Mark White; Leonard I Zon
Journal:  Zebrafish       Date:  2009-12       Impact factor: 1.985

8.  Cooperative interactions of PTEN deficiency and RAS activation in melanoma metastasis.

Authors:  C Nogueira; K-H Kim; H Sung; K H T Paraiso; J-H Dannenberg; M Bosenberg; L Chin; M Kim
Journal:  Oncogene       Date:  2010-08-16       Impact factor: 9.867

9.  Human cutaneous melanoma; a review of NRAS and BRAF mutation frequencies in relation to histogenetic subclass and body site.

Authors:  Anton Platz; Suzanne Egyhazi; Ulrik Ringborg; Johan Hansson
Journal:  Mol Oncol       Date:  2007-12-28       Impact factor: 6.603

10.  Lack of p53 mutations and loss of heterozygosity in non-cultured human melanocytic lesions.

Authors:  T Papp; M Jafari; D Schiffmann
Journal:  J Cancer Res Clin Oncol       Date:  1996       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.